Clinical Trial

Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache

Name: Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache — clinical trial record (NCT07515456)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this study is to compare the safety and efficacy of theophylline, sumatriptan, and gabapentin in the treatment of post-dural puncture headache.

Trial Details

NCT Number	NCT07515456
Lead Sponsor	Tanta University
Conditions	Theophylline, Sumatriptan, Gabapentin, Post-Dural Puncture Headache
Enrollment	75 participants
Start Date	2024-12-01
Primary Completion	2026-11-01 (estimated)
Study Completion	2026-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-07